Approved Use
PULMICORT RESPULES is developed and approved specifically for children 12 months to 8 years of age, to help prevent asthma symptoms that could lead to an attack.
PULMICORT RESPULES, an inhaled corticosteroid, is not a quick-relief medication and should NOT be used to treat an acute asthma attack
Important Safety Information
- Inhaled corticosteroids may cause a reduction in growth rate. The long-term effect on final adult height is unknown
- If switching to PULMICORT RESPULES from an oral (syrup or pill) corticosteroid, follow the doctor's instructions to help avoid health risks
- Tell the doctor if your child is exposed to chicken pox or measles
- Side Effects: In studies, side effects included respiratory infection, runny nose, earache, and coughing
Talk to your doctor about PULMICORT RESPULES.
Read the full Prescribing Information (PDF – 242KB)
Read Important Product Information for Patients.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.